Table 1 Subject characteristics by treatment group at baseline.
Placebo (n = 14) | G-PUR 2.0 g (n = 14) | G-PUR 2 * 2.0 g (n = 14) | |
|---|---|---|---|
Age (years) | 27 ± 5 | 27 ± 4 | 23 ± 2 |
Sex (m/f) | 7/7 | 7/7 | 7/7 |
Body mass index (kg/m2) | 21.5 ± 1.5 | 22.7 ± 2.3 | 22.6 ± 2.3 |
Haematocrit (%) | 40.2 ± 2.7 | 41.7 ± 3.3 | 41.0 ± 2.2 |
Whole blood lead (μg/l) | 16.2 ± 7.7 | 14.1 ± 10.0 | 14.8 ± 11.6 |
Plasma ferritin (µg/l) | 75.3 ± 64.5 | 80.8 ± 52.3 | 82.0 ± 56.9 |
Plasma creatinine (mg/dl) | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.8 ± 0.2 |